Chimerix Inc (CMRX)

3.01 +0.16 (+5.61%) USD  |  NASDAQ  |  Dec 20, 16:00
2.99 -0.02 (-0.66%) After-Hours: 20:00
More

Chimerix Enterprise Value: 134.48M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for CMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Cumberland Pharmaceuticals Inc 30.33M
Abbott Laboratories 205.55B
Emergent BioSolutions Inc 951.59M
Tonix Pharmaceuticals Holding Corp 94.06M
Geovax Labs Inc 13.02M

Enterprise Value Related Metrics

Net Income (Quarterly) -22.88M
Revenue (Quarterly) 0.026M
Total Expenses (Quarterly) 24.82M
EPS Diluted (Quarterly) -0.26
Profit Margin (Quarterly) -88.00K%
Earnings Yield -31.56%
Normalized Earnings Yield -31.56